Literature DB >> 19879508

Candida and the paediatric lung.

Alessandro C Pasqualotto1.   

Abstract

Although systemic candidosis is common in hospitalised children, Candida involvement of lung parenchyma is rare and usually perceived only at autopsy. The purpose of this article was to review the evidence regarding lung involvement in Candida infections, with special attention to paediatric patients. Primary Candida pneumonia is rare and usually associated with aspiration of oropharyngeal contents. The majority of cases of Candida pneumonia are secondary to haematological dissemination of Candida organisms from a distant site, usually the gastrointestinal tract or the skin. The diagnosis of pulmonary candidosis is difficult because there is no specific clinical or radiological presentation. In addition, the presence of Candida in sputum or other respiratory specimens mostly represents contamination. A definitive diagnosis of Candida pneumonia requires histopathologic proof of lung invasion in association with inflammation. Children can also be affected by pulmonary allergic reactions caused by Candida species. Treatment of Candida pneumonia is essentially the same as for candidaemia. Preliminary evidence suggests that patients with severe asthma sensitised to Candida species may also benefit from antifungal drugs.

Entities:  

Mesh:

Year:  2009        PMID: 19879508     DOI: 10.1016/j.prrv.2009.09.001

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  7 in total

1.  Invasive Candidiasis in Children: Challenges Remain.

Authors:  Mullai Baalaaji
Journal:  Indian J Crit Care Med       Date:  2022-06

Review 2.  Fungal infections of the lung in children.

Authors:  Paolo Toma; Alice Bertaina; Elio Castagnola; Giovanna Stefania Colafati; Maria Luisa D'Andrea; Andrea Finocchi; Vincenzina Lucidi; Angela Mastronuzzi; Claudio Granata
Journal:  Pediatr Radiol       Date:  2016-09-23

3.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

4.  Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study.

Authors:  B Minea; V Nastasa; R F Moraru; A Kolecka; M M Flonta; I Marincu; A Man; F Toma; M Lupse; B Doroftei; N Marangoci; M Pinteala; T Boekhout; M Mares
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-09-16       Impact factor: 3.267

5.  Candida pneumonia in intensive care unit?

Authors:  Ronny M Schnabel; Catharina F Linssen; Nele Guion; Walther N van Mook; Dennis C Bergmans
Journal:  Open Forum Infect Dis       Date:  2014-05-27       Impact factor: 3.835

6.  Isolated Candida infection of the lung.

Authors:  Yousef Shweihat; James Perry; Darshana Shah
Journal:  Respir Med Case Rep       Date:  2015-03-14

7.  Molecular analysis of fungal populations in patients with oral candidiasis using internal transcribed spacer region.

Authors:  Shinsuke Ieda; Masafumi Moriyama; Toru Takeshita; Toru Takashita; Takashi Maehara; Yumi Imabayashi; Shoichi Shinozaki; Akihiko Tanaka; Jun-Nosuke Hayashida; Sachiko Furukawa; Miho Ohta; Yoshihisa Yamashita; Seiji Nakamura
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.